Topical photodynamic therapy for localized scleroderma.

Therapy of localized scleroderma is unsatisfactory, with numerous treatments being used that have only limited success or considerable side-effects. The aim of this trial was to determine whether topical photodynamic therapy would be effective in patients with localized scleroderma. Five patients with progressive disease, in whom conventional therapies had failed, were treated by application of a gel containing 3% 5-aminolevulinic acid followed by irradiation with an incoherent lamp (40 mW/cm2, 10 J/cm2). The treatment was performed once or twice weekly for 3-6 months. In all patients the therapy was highly effective for sclerotic plaques, as measured by a quantitative durometer score and a clinical skin score. The only side-effect was a transient hyperpigmentation of the treated lesions. These cases document the beneficial effect of topical photodynamic therapy in localized scleroderma. Controlled trials are now necessary to confirm these preliminary results.

[1]  K. Scharffetter-Kochanek,et al.  Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts. , 1996, The Journal of investigative dermatology.

[2]  W. Morison.  Psoralen UVA therapy for linear and generalized morphea. , 1997, Journal of the American Academy of Dermatology.

[3]  T. Kanekura,et al.  Successful Treatment of Scleroderma with PUVA Therapy , 1996, The Journal of dermatology.

[4]  L. Chong,et al.  High-dose UVA1 radiation therapy for localized scleroderma. , 1998, Journal of the American Academy of Dermatology.

[5]  S. Jimenez,et al.  Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. , 1992, Archives of dermatology.

[6]  T. Ruzicka,et al.  High-dose UVA1 radiation therapy for localized scleroderma. , 1997, Journal of the American Academy of Dermatology.

[7]  R. Stern,et al.  Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. , 1998, Archives of dermatology.

[8]  T. Krieg,et al.  Management of localized scleroderma. , 1998, Seminars in cutaneous medicine and surgery.

[9]  V. Falanga,et al.  Use of a durometer to assess skin hardness. , 1993, Journal of the American Academy of Dermatology.

[10]  M Landthaler,et al.  Topical photodynamic therapy in dermatology. , 1996, Journal of photochemistry and photobiology. B, Biology.

[11]  Q. Peng,et al.  5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. , 1997, Cancer.

[12]  F. V. D. van den Hoogen,et al.  Reliability of two methods to assess morphea: skin scoring and the use of a durometer. , 1997, Journal of the American Academy of Dermatology.

[13]  M. Landthaler,et al.  Treatment of severe localized scleroderma by plasmapheresis report of three cases , 1995, The British journal of dermatology.

[14]  M Korell,et al.  Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. , 1999, Obstetrics and gynecology.

[15]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[16]  M. Kerscher,et al.  PUVA-bath-photochemotherapy of localized scleroderma , 1994 .

[17]  W. Sterry,et al.  Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.

[18]  K. Takeda,et al.  Decreased collagenase expression in cultured systemic sclerosis fibroblasts. , 1994, The Journal of investigative dermatology.